Peripheral blood lymphocytes (PBL) were obtained from heifers and wethers to assess the in vitro effects of swainsonine. Stimulated and unstimulated PBL ( 2 × 10 5 /well; 96 well plates) were incubated in the presence of swainsonine (2, .2, .02, .002, and 0 mg/mL; n = 32) for 72 h. Mitogens used to stimulate PBL were concanavalin A (ConA; 5 mg/mL), phytohemagglutinin-P (PHA-P; 5 mg/mL), phytohemagglutinin-M (PHA-M; 5 mg/mL), pokeweed mitogen (PWM; 5 mg/mL), and lipopolysaccharide (LPS; 10 mg/mL). Controls received no swainsonine or mitogen. Effects of swainsonine are expressed as a percentage of stimulation relative to control (stimulation index; SI). Unstimulated bovine PBL treated with 2 mg/mL of swainsonine exhibited a depressed ( P < .001; SI of 87 and 100 for 2 mg/mL and control, respectively; SE = 2.7) SI. At concentrations of .2 and 2 mg/mL, swainsonine inhibited ( P < .001; SI of 351, 310, and 464 for .2, 2, and 0 mg/mL, respectively; SE = 27.1) bovine PBL proliferative response to PHA-P. Swainsonine had a mitogenic effect on unstimulated ovine PBL at .2 and 2 mg/mL ( P < .05; SI of 118, 113, and 100 for .2 and 2 mg/mL and control, respectively; SE = 4.4). Swainsonine inhibited ovine proliferative responses to PHA-P at .2 and 2 mg/mL ( P < .005; SI of 190, 178, and 228 for .2, 2, and 0 mg/mL, respectively; SE = 9.4) and to PHA-M at .002 and 2 mg/mL ( P < .03; SI of 165, 167, and 192 for .002, 2, and 0 mg/mL, respectively; SE = 7.9). The opposing responses of unstimulated ovine (mitogenic) and bovine (antiproliferative) PBL to swainsonine indicates a differential species response. Swainsonine suppression of PHA-P-induced proliferation would indicate a negative effect on ovine and bovine T-cell function.
Introduction
The primary toxicant in locoweeds is swainsonine, an indolizidine alkaloid (Molyneux and James, 1982) and specific inhibitor of a-mannosidase enzymes (Tulsiani et al., 1982) . Inhibition of enzymes by swainsonine causes increased production of hybrid (Tropea et al., 1988; Elbein, 1989 ) and high-mannosetype glycoproteins (Kang et al., 1993) . Lymphocytes are highly dependent on glycosylated proteins for receptor function, adhesion, recognition, and many other cellular functions (Weiss, 1989) . Thus, lymphocytes are a potential target of swainsonine and its effects. Sharma et al. (1984) reported a decreased proliferation of phytohemagglutinin-stimulated whole blood lymphocyte cultures obtained from sheep that were consuming locoweed. This finding indicates that swainsonine affects ruminant-derived lymphocytes. However, because of the limited number of mitogens used and unknown serum swainsonine concentrations, the dose-response and mechanistic effects of swainsonine were not determined from this study.
Most locoweed studies have focused on feeding high levels (>10%) of locoweed, which generates serum swainsonine concentrations of .15 to .58 mg/mL in sheep and cattle (Pulsipher et al., 1994; Stegelmeier et al., 1995) . In addition, a differential response to locoweed between ovine and bovine species has not been established. Limited data have been published with regard to the effects of locoweed consumption that induces serum swainsonine levels less than .15 mg/mL. Therefore, the objectives of this study were to determine dose-response effects of swainsonine on ruminant-derived peripheral blood lymphocytes ( PBL) in vitro, to define the differences, if any, between bovine and ovine dose-response effects of Figure 1 . Effect of swainsonine (72 h) on unstimulated bovine (SE = 2.7; n = 32) and ovine (SE = 4.4; n = 32) peripheral blood lymphocytes in vitro. Stimulation index expressed as a percentage of unstimulated control (0 mg/mL swainsonine). *Different from unstimulated control (P < .001). **Different from unstimulated control (P < .03). swainsonine, and to delineate possible mechanistic effects of swainsonine on ruminant lymphoblastogenesis through the use of selected mitogens.
Materials and Methods

Peripheral Blood Lymphocyte Collection
Four heifers (385 ± 22.7 kg) and four wethers (47.6 ± 2.5 kg) were used for PBL collections. Bovine and ovine PBL were isolated with Histopaque-1077 (Sigma Chemical Co., St. Louis, MO) density sedimentation (Kanof and Smith, 1991) . Venous blood was aseptically obtained from the jugular vein in heparinized tubes and mixed promptly with an equal volume of PBS (10 mM; pH = 7.4). Blood/PBS was layered onto Histopaque-1077 in 15mL polypropylene conical tubes. Tubes were centrifuged at 630 × g for 30 min and 778 × g for an additional 10 min to collect PBL on top of the Histopaque-1077. Lymphocytes were removed and washed twice with Hank's balanced salts solution (pH = 7.4; Sigma Chemical). Cells were then transferred to a polystyrene culture flask containing culture medium (pH = 7.4; RPMI 1640, Sigma Chemical; 10% heat-inactivated fetal bovine serum, Cellgro, Herndon, VA; 100 units/mL penicillin and 100 mg/mL streptomycin, Sigma Chemical). Peripheral blood lymphocytes were incubated for 1 h at 37°C with 5% CO 2 and humidified air to remove monocytes adhered to the flask (Kanof and Smith, 1991) . Peripheral blood lymphocytes were pelleted and resuspended in culture medium. Cell counts and viability were determined by trypan blue exclusion assay (Sigma Chemical).
Peripheral blood lymphocytes ( 2 × 10 5 /well) were transferred to a 96-well microtiter plate that contained culture medium and treatment ( n = 32). Total volume per well was 100 mL. Bovine and ovine PBL were stimulated with either concanavalin A ( ConA; T-cell stimulant; 5 mg/mL), phytohemagglutinin-P ( PHA-P; T-cell stimulant; 5 mg/mL), phytohemagglutinin-M ( PHA-M; T-cell stimulant; 5 mg/mL), pokeweed mitogen ( PWM; T-and B-cell stimulant; 5 mg/ mL), or lipopolysaccharide ( LPS; B-cell stimulant; 10 mg/mL). Mitogens were obtained from Sigma Chemical. Cells then received swainsonine (synthetic; Sigma Chemical) treatment (0, .002, .02, .2, or 2 mg/mL) and were incubated for 72 h at 37°C with 5% CO 2 and humidified air. Unstimulated controls received no mitogen or swainsonine. After incubation, cellular proliferation was determined with a MTS tetrazolium assay (CellTiter 96 ® AQ ueous Assay, Promega, Madison, WI) using a microtiter plate reader (MRX HD, Dynex Laboratories, Chantilly, VA). This assay measures the amount of formazan compound produced from the cellular conversion of a tetrazolium salt (MTS). The formazan compound is soluble in tissue culture medium and can be measured directly in a 96-well plate (Buttke et al., 1993) . To each well containing cell culture, 20 mL of MTS solution was added during the last 2 h of incubation. After incubation was complete, the optical density ( OD) of each well was measured at 490 nm. Proliferation was expressed as a percentage of unstimulated control (i.e., stimulation index, SI; SI = ([OD of treated well/ OD of unstimulated control well] × 100).
Statistical Analyses
All experiments were arranged and analyzed as randomized complete block designs, with animal serving as the blocking factor. Each mitogen was treated as a separate experiment ( n = 32) within animal species. Data were analyzed by one-way ANOVA using JMP 3.1 (SAS, 1994). Significant treatment differences ( P < .05) were separated using linear contrasts.
Results and Discussion
Swainsonine and Unstimulated Lymphocytes
Compared with unstimulated control, swainsonine was inhibitory ( P < .001) to unstimulated bovine PBL at 2 mg/mL (Figure 1 ). This result suggested a possible antiproliferative effect of swainsonine. However, ovine PBL were stimulated by .2 ( P < .004) and 2 ( P < .03) mg/mL of swainsonine (Figure 1 ) when compared with unstimulated control. The differ- (72 h) on phytohemagglutinin-P stimulated bovine (SE = 27.1; n = 32) and ovine (SE = 9.4; n = 32) peripheral blood lymphocytes in vitro. Stimulation index expressed as a percentage of unstimulated control. Fixed line represents unstimulated control; 0 mg/mL swainsonine represents stimulated control. All treatments are different from unstimulated control (P < .001). *Different from 0 mg/mL swainsonine (P < .003). **Different from 0 mg/mL swainsonine (P < .02).
ence in species response is unknown at this time. Differential modification of receptor sites or alteration of intracellular transport of newly synthesized glycoproteins are possible contributing causes for the observed differences.
Swainsonine and Concanavalin A-Stimulated Lymphocytes
Concanavalin A-stimulated bovine (Figure 2 ) and ovine ( Figure 2 ) PBL were not affected by swainsonine when compared with stimulated control. Bowlin and Sunkara (1988) observed that swainsonine at 10.0 mg/mL enhanced ConA-induced human PBL interleukin ( IL)-2 receptor expression and IL-2 production and proliferation. Swainsonine increases high-mannose oligosaccharides (Kang et al., 1993) and ConA binding sites (Yagita et al., 1992) on lymphocyte cell surfaces. Concanavalin A specifically recognizes the trimannoside core of many complex glycoproteins (Naismith and Field, 1996) and induces a mitogenic effect by readily binding the cluster of differentiation 3 ( CD3) entity of the T-cell receptor complex (TCR; Bowlin and Sunkara, 1988) . The CD3 is responsible for antigen recognition presented by the accessory cells through the major histocompatibility complex II proteins and is the primary site of specific activation of the T-cell. The heavily glycosylated CD3 is a potential target of high-mannose oligosaccharide accumulation induced by swainsonine. Therefore, in human systems, augmentation of ConA stimulation by swainsonine could occur via modification of CD3. The lack of similar effects observed in this study may be due to short duration of exposure, low swainsonine concentrations, or the inability of swainsonine to alter the ruminant CD3 complex. Increasing the affinity of CD3 receptor sites for antigens would be beneficial by allowing a larger, quicker, and more specific recognition of invading antigens.
Swainsonine and Phytohemagglutinin-PStimulated Lymphocytes
Swainsonine decreased proliferative responses of bovine ( P < .003; Figure 3 ) and ovine ( P < .005; Figure 3 ) PBL to PHA-P at .2 and 2 mg/mL when compared with stimulated control. Sharma et al. (1984) reported that whole blood lymphocyte cultures from sheep that were consuming locoweed had a decreased response to PHA. Likewise, human PBL also express decreased responsiveness to PHA when treated with 10 mg/mL swainsonine (Myc et al., 1991) . Phytohemagglutinin-P is proposed to activate T-cells via the CD2 antigen (O'Flynn et al., 1986) . Triggering the CD2 complex results in nonspecific T-cell activation by endogenous IL-2 production, release, and subsequent binding to IL-2 receptors (Meuer et al., 1984) . The CD2 complex is activated by binding to (72 h) on phytohemagglutinin-M-stimulated bovine (SE = 25.5; n = 32) and ovine (SE = 7.9; n = 32) peripheral blood lymphocytes in vitro. Stimulation index expressed as a percentage of unstimulated control. Fixed line represents unstimulated control; 0 mg/mL swainsonine represents stimulated control. All treatments are different from unstimulated control (P < .001). **Different from 0 mg/mL swainsonine (P < .01). (72 h) on pokeweed mitogen-stimulated bovine (SE = 14.6; n = 32) and ovine (SE = 6.1; n = 32) peripheral blood lymphocytes in vitro. Stimulation index expressed as a percentage of unstimulated control. Fixed line represents unstimulated control; 0 mg/mL swainsonine represents stimulated control. All bovine treatments are different from unstimulated control (P < .001). a Different from 0 mg/mL swainsonine (P < .003). *Different from unstimulated control (P < .003).
CD2 counter receptors on the accessory cell during initial presentation of antigen to the TCR/CD3 complex (Huet et al., 1986) . Once TCR/CD3 binds to the antigen, specific activation of the T-cell occurs, and nonspecific activation via the CD2 is down-regulated (Meuer et al., 1984) . If the mitogenic effect of swainsonine on ovine PBL (Figure 1 ) is partially accomplished through modification of CD3, then a triggering of CD3 could initiate a decrease in activation stimulus through the CD2. Thus, proliferative responses of T-cells to PHA-P would be decreased. In support of this, PHA binding sites were decreased on human PBL treated with swainsonine (.5 mg/mL), whereas ConA binding sites were increased (Fujieda et al., 1994) . Additionally, decreased responsiveness of the PBL to PHA-P could occur by alteration of the CD2 glycoproteins by swainsonine. Because CD2 antigens are involved in the cell-mediated response and are the major activation receptor for young thymocytes (Parslow, 1994) , alteration of CD2 function by swainsonine could lead to an impaired immune response of ruminant animals.
Swainsonine and Phytohemagglutinin-MStimulated Lymphocytes
The effects of swainsonine treatment on PHA-Mstimulated bovine and ovine PBL are presented in Figure 4 . Phytohemagglutinin-M-induced lymphocyte proliferation is not associated solely with CD2 antigens. Part of the mitogenic effect of PHA-M is thought to be associated with the CD3/TCR complex, as is seen with ConA (O'Flynn et al., 1986) . Therefore, PHA-Mstimulated PBL should express a similar response to swainsonine treatment, as did ConA-stimulated PBL. Even though the proliferative responses of bovine (Figure 4 ) PBL were consistent with this hypothesis, ovine PBL were inhibited ( P < .02; Figure 4 ) by .002-and 2-mg/mL swainsonine treatments, further indicating a differential response of ovine and bovine PBL to swainsonine. The reason that ovine PBL treated with .02 and .2 mg/mL swainsonine did not respond as did the .002 and 2 mg/mL treatments is unknown at this time.
Swainsonine and Pokeweed Mitogen-Stimulated Lymphocytes
No response of PWM-stimulated bovine PBL to swainsonine was observed ( Figure 5 ). This finding agrees with results reported by Sharma et al. (1984) and Tulp et al. (1986) . Even though swainsonine does not seem to affect proliferative responses of human PBL to PWM, production of immunoglobulin from Bcells is strongly inhibited (Tulp et al., 1986) . In contrast, Karasuno et al. (1992) observed that human PBL treated with swainsonine (10 mg/mL) had a Figure 6 . Effect of swainsonine (72 h) on lipopolysaccharide-stimulated bovine (SE = 3.5; n = 32) and ovine (SE = 20.2; n = 32) peripheral blood lymphocytes in vitro. Stimulation index expressed as a percentage of unstimulated control. Fixed line represents unstimulated control; 0 mg/mL swainsonine represents stimulated control. All ovine treatments are different from unstimulated control (P < .001). *Different from unstimulated control (P < .003).
decreased response to PWM and suggested that the decrease resulted from the alteration of B-cell membrane oligosaccharides. At 0 mg/mL of swainsonine, ovine PBL failed to respond to PWM ( Figure 5 ). Only at higher concentrations of swainsonine (.2 and 2 mg/ mL) was a proliferation of ovine lymphocytes observed. In ovine cell cultures treated with .2 and 2 mg/ mL swainsonine alone, swainsonine was mitogenic (Figure 1) . Therefore, proliferation of ovine PBL at the .2 and 2 mg/mL swainsonine treatments may be due to direct stimulation induced by swainsonine. The reason for the lack of response of ovine PBL to PWM is unknown at this time. Further investigation is needed to determine the effects of swainsonine on PWMstimulated ovine PBL.
Swainsonine and LipopolysaccharideStimulated Lymphocytes
Lipopolysaccharide is a cell wall component of most Gram-negative bacteria and can directly stimulate Bcell proliferation and immunoglobulin secretion (Anderson et al., 1972) . Lipopolysaccharide stimulation of bovine ( Figure 6 ) and ovine ( Figure 6 ) PBL was not affected by swainsonine treatments. Because swainsonine interferes with immunoglobulin production in human PBL, measurement of immunoglobulin production may be a better assessment of the effect of swainsonine on B-cell function.
Conclusions
The stimulatory and inhibitory effects of swainsonine on ruminant PBL occur at levels of .2 mg/mL or greater (Figures 1, 3, and 4) , well into the range that causes clinical toxicosis. A qualitative difference in ovine and bovine PBL treated with swainsonine alone and PHA-M would indicate a differential species response to swainsonine. Suppressive effects of swainsonine on PHA-P stimulation in both species indicate an adverse effect on ruminant immunocompetence. Swainsonine concentrations less than .02 mg/mL do not significantly affect bovine and ovine PBL in vitro as determined with selected mitogens. These effects of swainsonine seem to occur through involvement with the PHA activation sites of the T-cell.
Implications
This in vitro study indicates that low levels of swainsonine do not adversely affect sheep and cattle immune systems. Therefore, it may be possible for ruminants (i.e., bovine and ovine) that consume locoweed to maintain a viable immune system if serum swainsonine concentrations do not exceed .02 mg/mL for more than a 72-h period. If future studies, in vitro and in vivo, continue to show similar results, the development of bovine and ovine grazing systems in locoweed-infested areas may be possible. Future in vitro and in vivo studies are needed to assess possible cumulative effects of swainsonine on ruminant immune systems exposed to swainsonine for more than 72 h.
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